Skip to main content

Closed

RNAZ: TransCode Therapeutics, Inc. Fundamental Analysis | finqOS

Healthcare · Biotechnology

52W Range

4thpctl

Volume

0.49×avg

Market Cap

4.83MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading analysis data...

TransCode Therapeutics, Inc.

RNAZNASDAQ Capital Market·USD·Closed

TransCode Therapeutics, Inc.

RNAZNASDAQ·USD·Closed

$4.56

−13.14%

$4.56

−$0.69 (13.14%)

52W Range

4thpctl

Volume

0.49×avg

Mkt Cap

4.83MUSD

P/E

-0.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings